Direct oral anticoagulant (DOAC) prophylaxis vs no prophylaxis
Minor bleeding · ambulatory people with cancer without venous thromboembolism receiving systemic therapy
Direct oral anticoagulant (DOAC) prophylaxis showed no clear difference in minor bleeding compared with no prophylaxis (low certainty).
1 finding from 1 review
- Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation 2021 · Cochrane Headline outcomes onlyRR 3.58 [0.55, 23.44]3 studies · 1440 participantsLow